fluorescein has been researched along with 2',7'-dichlorodihydrofluorescein diacetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, JW; Metcalfe, DD; Swindle, EJ | 1 |
| Alexandre, J; Annereau, M; Batteux, F; Chéreau, C; Dauphin, A; Goldwasser, F; Lemare, F; Mongaret, C; Nicco, C; Thomas-Schoemann, A; Weill, B | 1 |
2 other study(ies) available for fluorescein and 2',7'-dichlorodihydrofluorescein diacetate
| Article | Year |
|---|---|
Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide.
Topics: Animals; Antigens; Blotting, Western; Cells, Cultured; Female; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Immunoblotting; Immunoglobulin E; Indicators and Reagents; Interferon-gamma; Lipopolysaccharides; Macrophages; Mast Cells; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Rats; Reactive Oxygen Species; Signal Transduction; Species Specificity; Time Factors | 2004 |
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Enzyme Inhibitors; Female; Fluorescein; Fluoresceins; Humans; Immunotherapy, Adoptive; Lymphocyte Activation; Lymphocyte Depletion; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Oxides; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase; T-Lymphocytes, Regulatory | 2012 |